PCP
ICUI icon

Perbak Capital Partners’s ICU Medical ICUI Stock Holding History

Perbak Capital Partners’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,631
Closed -$986K – 123
2026
Q1 		$986K Buy
7,631
+4,626
+154% +$665K 0.24% 66
2025
Q4 		$429K Sell
3,005
-8,241
-73% -$1.1M 0.13% 74
2025
Q3 		$1.35M Buy
11,246
+6,547
+139% +$830K 0.24% 69
2025
Q2 		$621K Buy
+4,699
New +$637K 0.14% 151

Other funds holding ICUI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perbak Capital Partners's ICUI Position: Q2 2026 in Review

Perbak Capital Partners sold out of ICU Medical (ICUI) in Q2 2026, closing a stake of 7,631 shares — an estimated $986K sold.

Perbak Capital Partners first reported a position in ICUI in Q2 2025 and held it in 4 quarters. The position peaked at $1.35M in Q3 2025. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Perbak Capital Partners reported no remaining ICU Medical position as of Q2 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 7,631 ICU Medical shares in Q2 2026, an estimated $986K.
  • Perbak Capital Partners first reported a position in ICU Medical in Q2 2025 and held it in 4 quarters.
  • Perbak Capital Partners's ICU Medical position peaked at $1.35M in Q3 2025.
  • 289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.